Inflammation: What's There and What's New?

被引:5
|
作者
Calhelha, Ricardo C. [1 ,2 ]
Haddad, Hala [1 ,2 ]
Ribeiro, Lucia [1 ,2 ]
Heleno, Sandrina A. [1 ,2 ]
Carocho, Marcio [1 ,2 ]
Barros, Lillian [1 ,2 ]
机构
[1] Inst Politecn Braganca, Ctr Invest Montanha CIMO, Campus Santa Apolonia, P-5300253 Braganca, Portugal
[2] Inst Politecn Braganca, Lab Sustentabilidade & Tecnol Regioes Montanha Sus, Campus Santa Apolonia, P-5300253 Braganca, Portugal
来源
APPLIED SCIENCES-BASEL | 2023年 / 13卷 / 04期
关键词
inflammation; synthetic anti-inflammatory agents; natural anti-inflammatory agents; mechanisms of action; in vitro and in vivo anti-inflammatory assays; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NF-KAPPA-B; TISSUE FACTOR; ZINGIBER-OFFICINALE; IMMUNE-RESPONSE; TGF-BETA; COMPLEMENT; MECHANISMS; LOCALIZATION; APOPTOSIS;
D O I
10.3390/app13042312
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Since the dawn of man, inflammation has been known to humanity, as it is marked by pain. Inflammation processes are related to serious chronic diseases with irreversible damage to the organism, being crucial for the development of anti-inflammatory agents. Among the existing anti-inflammatory drugs, non-steroidal and glucocorticoids are commonly used; however, these compounds have been described as responsible for the increased risk of upper gastrointestinal complications and many other side effects. Therefore, it is not shocking that ethnobotany leads most modern studies on the discovery of anti-inflammatory agents obtained from natural matrices. Extracts from plants and isolated substances have demonstrated anti-inflammatory effects in a set of in vitro and in vivo anti-inflammatory models. This review describes inflammation processes with an emphasis on the most common related diseases, while also describing the most promising natural anti-inflammatory agents, by reporting on their obtention processes, mechanisms of action, and applications.
引用
收藏
页数:26
相关论文
共 50 条
  • [31] Fintech: what's old, what's new?
    Boot, Arnoud
    Hoffmann, Peter
    Laeven, Luc
    Ratnovski, Lev
    JOURNAL OF FINANCIAL STABILITY, 2021, 53
  • [32] What's New(s)?
    Chemical Processing, 2022, 84 (06):
  • [33] Demyelinating CMT-what's known, what's new and what's in store?
    Brennan, Kathryn M.
    Bai, Yunhong
    Shy, Michael E.
    NEUROSCIENCE LETTERS, 2015, 596 : 14 - 26
  • [34] IT'S WHAT IT WAS, IT'S WHAT IT IS, IT'S WHAT IT WILL BE
    Echazarra, Ane Rubio
    AUSART, 2024, 12 (02): : 131 - 147
  • [35] WHAT'S NEW IN OUR UNDERSTANDING AND TREATMENT OF INFLAMMATION IN CF
    Koutsokera, Angela
    PEDIATRIC PULMONOLOGY, 2019, 54 : S84 - S85
  • [36] What's old and what's new about neutrinos
    Cowsik, R
    CURRENT SCIENCE, 1998, 75 (06): : 558 - 563
  • [37] Rosacea Treatments What's New and What's on the Horizon?
    Gallo, Rosella
    Drago, Francesco
    Paolino, Stefania
    Parodi, Aurora
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2010, 11 (05) : 299 - 303
  • [38] Osteoporosis Treatments: What's New and What's Coming?
    Lindsay, Robert
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (12): : 1340 - 1340
  • [39] What's new, what's best in symptom management?
    Miaskowski, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 4 - 4
  • [40] Process Control: What's New, What's Next
    Carter, Russell A.
    E&MJ-ENGINEERING AND MINING JOURNAL, 2010, 211 (01): : 42 - 44